These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27697495)

  • 1. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation.
    Gentile E; Liuzzi GM
    Drug Discov Today; 2017 Feb; 22(2):299-313. PubMed ID: 27697495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactives from Marine Organisms and their Potential Role as Matrix Metalloproteinase Inhibitors.
    Thomas NV; Monica Diyya AS; Kim SK; Faraj KA; Ghafoor DD; Qian ZJ; Tigabu BM
    Curr Pharm Des; 2022; 28(41):3351-3362. PubMed ID: 36411577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there new hope for therapeutic matrix metalloproteinase inhibition?
    Vandenbroucke RE; Libert C
    Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
    Li W; Saji S; Sato F; Noda M; Toi M
    Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase inhibitors: a patent review (2011 - 2013).
    Li NG; Tang YP; Duan JA; Shi ZH
    Expert Opin Ther Pat; 2014 Sep; 24(9):1039-52. PubMed ID: 25098768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.
    Zhang C; Kim SK
    Mar Drugs; 2009 Mar; 7(2):71-84. PubMed ID: 19597572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloproteinases and their inhibitors in neurological disease.
    Lopez-Navarro ER; Gutierrez J
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):27-38. PubMed ID: 34851449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential matrix metalloproteinase inhibitors from edible marine algae: a review.
    Thomas NV; Manivasagan P; Kim SK
    Environ Toxicol Pharmacol; 2014 May; 37(3):1090-100. PubMed ID: 24780533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.
    Fields GB
    Cells; 2019 Aug; 8(9):. PubMed ID: 31461880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seesaw of matrix metalloproteinases (MMPs).
    Kapoor C; Vaidya S; Wadhwan V; ; Kaur G; Pathak A
    J Cancer Res Ther; 2016; 12(1):28-35. PubMed ID: 27072206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase enzymes and their naturally derived inhibitors: novel targets in photocarcinoma therapy.
    Gupta A; Kaur CD; Jangdey M; Saraf S
    Ageing Res Rev; 2014 Jan; 13():65-74. PubMed ID: 24355347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update.
    Chaudhary AK; Chaudhary S; Ghosh K; Nadkarni A
    Asian Pac J Cancer Prev; 2016; 17(7):3043-51. PubMed ID: 27509927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Inhibitors of Medium-Size S1' Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery.
    Baidya SK; Banerjee S; Adhikari N; Jha T
    J Med Chem; 2022 Aug; 65(16):10709-10754. PubMed ID: 35969157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Synthetic Matrix Metalloproteinase Inhibitors by Fluorogenic Substrate Assay.
    Lively TJ; Bosco DB; Khamis ZI; Sang QX
    Methods Mol Biol; 2016; 1406():161-70. PubMed ID: 26820953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibitors (MMPIs) as attractive therapeutic targets: Recent progress and current challenges.
    Shi Y; Ma X; Fang G; Tian X; Ge C
    NanoImpact; 2021 Jan; 21():100293. PubMed ID: 35559782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
    Yang JS; Lin CW; Su SC; Yang SF
    Expert Opin Drug Metab Toxicol; 2016; 12(2):191-200. PubMed ID: 26852787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP inhibitors and cancer treatment trials, limitations and hopes for the future.
    Tlatli R; El Ayeb M
    Arch Inst Pasteur Tunis; 2013; 90(1-4):3-21. PubMed ID: 26012207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain.
    Kuhad A; Singh P; Chopra K
    Expert Opin Ther Targets; 2015 Feb; 19(2):177-85. PubMed ID: 25243524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
    Jian M; Sun X; Cheng G; Zhang H; Li X; Song F; Liu Z; Wang Z
    J Nat Prod; 2022 Oct; 85(10):2424-2432. PubMed ID: 36122348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
    Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.